Humankind Investments’s iShares Biotechnology ETF IBB Stock Holding History

Humankind Investments’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$8.44M	Sell	50,000 -4,500	-8%	-$769K	4.82%	9
2025 Q4	$9.2M	Buy	54,500 +50,000	+1,111%	+$8.12M	4.13%	10
2025 Q3	$650K	Hold	4,500	–	–	0.15%	73
2025 Q2	$569K	Hold	4,500	–	–	0.14%	78
2025 Q1	$576K	Hold	4,500	–	–	0.15%	79
2024 Q4	$595K	Hold	4,500	–	–	0.15%	75
2024 Q3	$655K	Hold	4,500	–	–	0.24%	62
2024 Q2	$618K	Hold	4,500	–	–	0.16%	68
2024 Q1	$617K	Hold	4,500	–	–	0.16%	68
2023 Q4	$611K	Buy	+4,500	New	+$549K	0.18%	65

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return

Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Humankind Investments's IBB Position: Q1 2026 in Review

Humankind Investments reduced its iShares Biotechnology ETF (IBB) stake by 8.3% in Q1 2026, selling an estimated $769K and leaving 50,000 shares worth $8.44M. The position accounts for 4.82% of the portfolio, ranked #9.

Humankind Investments first reported a position in IBB in Q4 2023 and has held it in 10 quarters since. The position peaked at $9.2M in Q4 2025. 917 funds tracked by Wall St. Rank hold IBB as of Q1 2026.

Humankind Investments held 50,000 shares of iShares Biotechnology ETF worth $8.44M as of Q1 2026.
Humankind Investments sold 4,500 iShares Biotechnology ETF shares in Q1 2026, an estimated $769K.
iShares Biotechnology ETF made up 4.82% of Humankind Investments's portfolio in Q1 2026, its #9 holding.
Humankind Investments first reported a position in iShares Biotechnology ETF in Q4 2023 and has held it in 10 quarters since.
Humankind Investments's iShares Biotechnology ETF position peaked at $9.2M in Q4 2025.
917 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2026.

Based on Humankind Investments's 13F filing for Q1 2026, filed 15 May 2026.